on May 13, 2004
Published online before print May 13, 2004, doi: 10.1161/01.STR.0000129788.26346.18
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Submitted on December 24, 2003
From the Section on Pharmacology, Division of Intramural Research Programs (H.A., J.Z., M.M., J.M.S.), National Institute of Mental Health, National Institutes of Health, Department of Health and Human Services, Bethesda, Md; and the Institute of Cell Biology (H.I.), University of Bern, Bern, Switzerland. * To whom correspondence should be addressed. E-mail: Saavedrj{at}intra.nimh.nih.gov.
Background and Purpose--The spontaneously hypertensive rat (SHR) is vulnerable to brain ischemia and stress and exhibits a chronically stimulated brain angiotensin II system, cerebrovascular hypertrophy, and inflammation. Pretreatment with angiotensin II type 1 (AT1) receptor antagonists protects from brain ischemia and from stress and prevents the development of stress-induced gastric ulcers in part by reducing inflammation in the gastric mucosa. We studied whether AT1 receptor antagonists could exert antiinflammatory effects in the brain vasculature as a mechanism for their protective effects against ischemia. Methods--Ten-week-old SHR and normotensive Wistar-Kyoto male rats received the AT1 receptor antagonist candesartan (0.3 mg/kg per day) or vehicle for 28 days via osmotic minipumps. We studied AT1 receptors, intercellular adhesion molecule-1 (ICAM-1), endothelial nitric oxide synthase (eNOS), and number of macrophages by immunohistochemistry and Western blots. Results--We found increased endothelial AT1 receptor expression of brain microvessels and middle cerebral artery of SHR. Brain AT1 receptor inhibition reversed the pathological vascular hypertrophy, increased and normalized eNOS expression, and decreased ICAM-1 expression and the number of adherent and infiltrating macrophages in cerebral vessels of SHR. Conclusions--The antiinflammatory effects of AT1 receptor antagonists may be an important mechanism in protecting against ischemia.
Revised on March 10, 2004
Accepted on March 17, 2004
Angiotensin II AT1 Receptor Blockade Reverses Pathological Hypertrophy and Inflammation in Brain Microvessels of Spontaneously Hypertensive Rats
Hiromichi Ando MD, PhD;
Key words: cerebral arteries • inflammation • intercellular adhesion molecule-1 • middle cerebral artery • cerebrovascular disorders
This article has been cited by other articles:
 |
|
 |
|
  E. Sanchez-Lemus, J. Benicky, J. Pavel, I. M. Larrayoz, J. Zhou, M. Baliova, T. Nishioku, and J. M. Saavedra Angiotensin II AT1 blockade reduces the lipopolysaccharide-induced innate immune response in rat spleen Am J Physiol Regulatory Integrative Comp Physiol, May 1, 2009; 296(5): R1376 - R1384. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. M. De Silva, B. R.S. Broughton, G. R. Drummond, C. G. Sobey, and A. A. Miller Gender Influences Cerebral Vascular Responses to Angiotensin II Through Nox2-Derived Reactive Oxygen Species Stroke, April 1, 2009; 40(4): 1091 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. A. McCarthy, A. Vinh, J. K. Callaway, and R. E. Widdop Angiotensin AT2 Receptor Stimulation Causes Neuroprotection in a Conscious Rat Model of Stroke * Supplemental Materials and Methods Stroke, April 1, 2009; 40(4): 1482 - 1489. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Inaba, M. Iwai, Y. Tomono, I. Senba, M. Furuno, H. Kanno, H. Okayama, M. Mogi, J. Higaki, and M. Horiuchi Exaggeration of Focal Cerebral Ischemia in Transgenic Mice Carrying Human Renin and Human Angiotensinogen Genes Stroke, February 1, 2009; 40(2): 597 - 603. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Inaba, M. Iwai, M. Furuno, Y. Tomono, H. Kanno, I. Senba, H. Okayama, M. Mogi, J. Higaki, and M. Horiuchi Continuous Activation of Renin-Angiotensin System Impairs Cognitive Function in Renin/Angiotensinogen Transgenic Mice Hypertension, February 1, 2009; 53(2): 356 - 362. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. Sanchez-Lemus, Y. Murakami, I. M. Larrayoz-Roldan, A. J. Moughamian, J. Pavel, T. Nishioku, and J. M. Saavedra Angiotensin II AT1 Receptor Blockade Decreases Lipopolysaccharide-Induced Inflammation in the Rat Adrenal Gland Endocrinology, October 1, 2008; 149(10): 5177 - 5188. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. Kozak, A. Kozak, M. H. Johnson, H. F. Elewa, and S. C. Fagan Vascular Protection with Candesartan after Experimental Acute Stroke in Hypertensive Rats: A Dose-Response Study J. Pharmacol. Exp. Ther., September 1, 2008; 326(3): 773 - 782. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Cipolla, J. Smith, N. Bishop, L. V. Bullinger, and J. A. Godfrey Pregnancy Reverses Hypertensive Remodeling of Cerebral Arteries Hypertension, April 1, 2008; 51(4): 1052 - 1057. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 I. M. Hajjar, M. Keown, P. Lewis, and A. Almor Angiotensin Converting Enzyme Inhibitors and Cognitive and Functional Decline in Patients with Alzheimer's Disease: An Observational Study American Journal of Alzheimer's Disease and Other Dementias, March 1, 2008; 23(1): 77 - 83. [Abstract] [PDF]
|
|
|
|
|
|
K. Tsukuda, M. Mogi, J.-M. Li, J. Iwanami, L.-J. Min, A. Sakata, T. Fujita, M. Iwai, and M. Horiuchi Amelioration of Cognitive Impairment in the Type-2 Diabetic Mouse by the Angiotensin II Type-1 Receptor Blocker Candesartan Hypertension, December 1, 2007; 50(6): 1099 - 1105. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Yamashita, A. Sekiguchi, T. Kato, T. Tsuneda, Y.-k. Iwasaki, K. Sagara, H. Iinuma, H. Sawada, and T. Aizawa Angiotensin type 1 receptor blockade prevents endocardial dysfunction of rapidly paced atria in rats Journal of Renin-Angiotensin-Aldosterone System, September 1, 2007; 8(3): 127 - 132. [Abstract] [PDF]
|
|
|
|
|
|
K.-H. Jung, K. Chu, S.-T. Lee, S.-J. Kim, E.-C. Song, E.-H. Kim, D.-K. Park, D.-I. Sinn, J.-M. Kim, M. Kim, et al. Blockade of AT1 Receptor Reduces Apoptosis, Inflammation, and Oxidative Stress in Normotensive Rats with Intracerebral Hemorrhage J. Pharmacol. Exp. Ther., September 1, 2007; 322(3): 1051 - 1058. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Ishikawa, E. Sekizuka, N. Yamaguchi, H. Nakadate, S. Terao, D. N. Granger, and H. Minamitani Angiotensin II type 1 receptor signaling contributes to platelet-leukocyte-endothelial cell interactions in the cerebral microvasculature Am J Physiol Heart Circ Physiol, May 1, 2007; 292(5): H2306 - H2315. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Toda, K. Ayajiki, and T. Okamura Interaction of Endothelial Nitric Oxide and Angiotensin in the Circulation Pharmacol. Rev., March 1, 2007; 59(1): 54 - 87. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Zhou, J. Pavel, M. Macova, Z.-X. Yu, H. Imboden, L. Ge, T. Nishioku, J. Dou, E. Delgiacco, and J. M. Saavedra AT1 Receptor Blockade Regulates the Local Angiotensin II System in Cerebral Microvessels From Spontaneously Hypertensive Rats Stroke, May 1, 2006; 37(5): 1271 - 1276. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Girouard, L. Park, J. Anrather, P. Zhou, and C. Iadecola Angiotensin II Attenuates Endothelium-Dependent Responses in the Cerebral Microcirculation Through Nox-2-Derived Radicals Arterioscler Thromb Vasc Biol, April 1, 2006; 26(4): 826 - 832. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Owen, J. Schrader, S. Luders, A. Kulschewski, F. Hammersen, K. Plate, J. Berger, W. Zidek, P. Dominiak, H. C. Diener, et al. MOSES: Superiority or Noninferiority? * Response: Stroke, February 1, 2006; 37(2): 337 - 338. [Full Text] [PDF]
|
|
|
|
 |
|
 N. Nagai, Y. Oike, K. Noda, T. Urano, Y. Kubota, Y. Ozawa, H. Shinoda, T. Koto, K. Shinoda, M. Inoue, et al. Suppression of Ocular Inflammation in Endotoxin-Induced Uveitis by Blocking the Angiotensin II Type 1 Receptor Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2925 - 2931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Zeng, Z. Yang, Z. Wang, J. Jones, X. Wang, J. Altea, A. J. Mangrum, U. Hopfer, D. R. Sibley, G. M. Eisner, et al. Interaction of Angiotensin II Type 1 and D5 Dopamine Receptors in Renal Proximal Tubule Cells Hypertension, April 1, 2005; 45(4): 804 - 810. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kazama, J. Anrather, P. Zhou, H. Girouard, K. Frys, T. A. Milner, and C. Iadecola Angiotensin II Impairs Neurovascular Coupling in Neocortex Through NADPH Oxidase-Derived Radicals Circ. Res., November 12, 2004; 95(10): 1019 - 1026. [Abstract] [Full Text] [PDF]
|
|